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Abstract.  Using RNase protection and oligonucleotide 
hybridization experiments, we have shown that U1 
precursors are derived by transcription of 3' flanking 
sequences. A  labeled SP6 transcript of one of the true 
U1  genes (pD2)  was able to protect a  subset of the 3' 
flanking sequences present in HeLa cytoplasmic U1 
RNA.  However, not all U1  precursors were protected 
using this probe,  suggesting that variant U1  precursor 
3' tail sequences are expressed in HeLa cells. This 
conclusion has been confirmed by hybridization of 
HeLa RNA samples with specific oligonucleotide 
probes representing variant U1  3' flanking sequences. 
Interestingly, these variant tail sequences contain the 
putative Sm antigen binding site, A(U)3-6G.  The con- 
servation of this flanking sequence through evolution 
suggests a  possible functional role for these precursor 
tails in ordering protein binding to U1  RNA. 
U 
1 RNA is a  highly abundant,  small nuclear RNA 
found in the nuclei of eucaryotic cells.  It is com- 
plexed with 8-10 proteins (14, 16, 47) forming a ribo- 
nucleoprotein (RNP) t particle  (snRNP).  The finding that 
UI RNA contains sequences complementary to intron-exon 
splice junctions in pre-messenger RNAs led to the hypothe- 
sis that U1 RNA might be required for mRNA splicing (22, 
41). This hypothesis was supported by the finding that anti- 
bodies directed against U1 snRNP inhibit both in vitro and 
in vivo splicing (18, 39, 51). Further confirmation that U1 is 
required for splicing comes from experiments demonstrating 
that specific degradation of the 5' end of U1 RNA also in- 
hibits in vitro splicing (4,  17,  18). The fact that antibodies 
to U1 snRNP recognize the protein components of U1 RNP 
and not U1 RNA alone, along with the finding that only U1 
RNP will bind specifically to 5' splice sites (36) suggests that 
it is the RNP form of U1 that functions in splicing. 
In the human genome there are estimated to be ,x,l,000- 
2,000 copies of U1 RNA genes (9, 31). Of these, 30-125 are 
thought to  represent  true  U1  genes,  while the remaining 
copies are thought to be pseudogenes (25, 31). The set of  true 
U1 genes are denoted as true genes based on sequence iden- 
tity with a human U1 RNA sequenced by Branlant et al., (5) 
and the ability to be transcribed both in Xenopus oocytes and 
in vitro (25,  31). 
Like other RNAs, U1 is apparently synthesized as a pre- 
cursor (11, 29, 52). Recent experirnents suggest that U1 pre- 
cursors are transported to the cytoplasm, where they associ- 
ate with snRNP proteins and undergo 3' terminal processing 
before returning to the nucleus. Since no introns have been 
found in U1 genes, and transcription apparently begins at the 
1. Abbreviations used in this paper: RNP, ribonucleoprotein; snRNP, small 
nuclear ribonucleoprotein particle. 
cap  site  (43),  it  has  been  presumed  that the  precursor- 
specific sequences are derived by transcription of Y flanking 
sequences. In further support of this hypothesis, recent ex- 
periments have established that some read-through transcrip- 
tion beyond the 3' end of the sequence found in mature U1 
does occur (20), and sequences responsible for the formation 
of 3' ends have been identified (13). 
We have been using RNase mapping to investigate the 
structure of U1 precursors in greater detail. Since all of the 
true genes that have been sequenced have identical 3' flank- 
ing sequences for the first 19 nucleotides (nO after the final 
nucleotide found in mature U1 RNA, it was surprising to find 
that a cloned copy of one of the true U1 genes (pD2; refer- 
ence 31) does not protect the total pattern of cytoplasmic U1 
precursors from RNase digestion when hybridized to these 
RNAs. This suggests that not all U1 precursors are derived 
via transcription of  the true U1 genes. Hybridization  of HeLa 
cell U1 RNA to specific oligonucleotides containing variant 
3' flanking sequences confirms this result, and suggests that 
the regulation of U1 RNA synthesis in human cells might be 
much more complex than was previously supposed. 
Materials and Methods 
Cell Lines, RNA Isolation, and Antisera 
HeLa cells were grown in suspension culture in Joklik's modified minimum 
essential media (Gibco, Grand Island, NY) supplemented with 5 % fetal calf 
serum. Cells were pulse-labeled for 45 min with [3H]uridine  as described 
(29) or labeled for 12-16 h with [3H]uridine  for long labeling studies and 
were then fractionated in RSB (0.01 M NaC1, 0.01 M Tris-HC1,  pH 7.2, and 
1.5 mM MgCI2) as described (40). We have experienced some variability 
in the purity of  cell fractions obtained by this procedure. Given this variabil- 
ity, plus the possibility of nuclear leakage during fractionation, we wish to 
emphasize that the terms nuclear and cytoplasmic reflect operational defini- 
tions, and do not necessarily reflect the true cellular localization of particu- 
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by phenol-chloroform extraction.  Where indicated, U1 RNA was isolated 
by antibody precipitation using protein A-Sepharose  chromatography  fol- 
lowed by phenol extraction as described (45-47). Hybrid selection of U1 
RNA was as described (29). Antisera used in this study were obtained from 
patients with systemic lupus erythematosus.  IgG was isolated from these pa- 
tients and was found to specifically  precipitate U1 snRNPs. 
Oligonucleotide Synthesis 
Oligodeoxynucleotides  were synthesized using the phosphoramidite  method 
(2) on a synthesizer (380A; Applied Biosystems,  Inc., Foster City, CA). 
Controlled pore glass served as the solid support (1). 
SP6 Transcriptions 
A human U1 gene, pD2, (31) was cloned into plasmids pSP64 and pSP65 
(Promega Biotech, Madison, WI). Plasmid SP64U1 contains the Bgl II-Eco 
RI fragment  ofpD2 cloned into the Barn HI and Eco RI sites in pSP64. Plas- 
mid pSP65cU1 contains the Bgl II-Rsa I fragment of pD2 cloned into the 
Barn HI and Sma I sites in pSP65.  RNA transcripts were generated from 
these plasmid constructs using SP6  polymerase (Boehringer Mannheim 
Diagnostics,  Inc., Houston, TX) folldwing the manufacturers instructions 
(Promega Biotech). The transcript from pSP64U1 contains U1 RNA begin- 
ning at the Bgl 1I site at -6 in addition to 34 nueleotides of polylinker se- 
quences at the 5' end. An RNA transcript complementary to UI was gener- 
ated from pSP65cU1 with transcription  of 25 polylinker sequences followed 
by cU1 RNA beginning at the Rsa I site (+194). Transcription was termi- 
nated at convenient restriction sites as described in the figure legends. 
RNase Digestion Experiments 
SP6-generated transcripts were hybridized to RNA isolated from HeLa cells 
in a buffer containing 0.4 M NaC1, 40 mM Pipes,  pH 6.4,  1.0 rnM EDTA, 
and 80% Formamide.  Samples were briefly denatured at 80°C and hybrid- 
ized for 12-16 h at 50°C.  Unhybridized sequences  were then digested  for 
1 h at 24°C in RNase digestion buffer (10 mM Tris-HCl, pH 7.5, 5 mM 
EDTA, 0.3 M NaC1, 2.0 ~tg/ml RNase TI, and 40 gg/ml RNase A) followed 
by treatment with 0.1  Ig/ml proteinase K and SDS (0.6%)  for 15 rain at 
370C. Remaining  undigested RNAs were phenol-chloroform  extracted in the 
presence of carrier tRNA (5  pg) and ethanol precipitated.  Reconstituted 
samples were run on a 10% polyacrylamide  gel containing 7.0 M urea. Gels 
were electrophoresed for 2-3 h at 20 mA, and either exposed  directly or 
fluorographed  as described (46, 47). 
Oligonucleotide Hybridizations 
RNAs were incubated in 3 vol of 6.15 M formaldehyde,  10x  SSC (Ix  is 
150 mM NaC1, 15 mM Sodium Citrate) at 65"C for 10 rain and subsequently 
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Figure 1. Construction of plasmids pSP64U1 and pSP65cU1. A hu- 
man U1 RNA gene (pD2, reference 31) was subcloned into plasmids 
pSP64 and pSP65 as detailed in Materials and Methods. The solid 
arrow refers to the "Paq I  site at position +115 and the open arrow 
refers to the Hpa II site at  +73. 
Figure2. The 3' flanking sequence of the human U1 RNA true gene, 
pD2, is expressed in HeLa cells. U1 RNAs were isolated from nu- 
clear (lanes 3 and 4) and cytoplasmic (lanes 2  and 5) fractions of 
HeLa cells using anti(U1)RNP antisera followed by phenol extrac- 
tion.  These RNAs were hybridized with 32p-labeled RNA probes 
synthesized from an SP6 vector (see Fig.  1) containing the true hu- 
man U1  gene, pD2,  which had been digested with either Hpa II 
(lanes 2 and 3) or Taq I (lanes 4 and 5). After digestion of unhybrid- 
ized sequences with RNases A and T1, protected RNAs were puri- 
fied by phenol extraction and ethanol precipitation. Lanes 1 and 6 
contain markers derived from DNA sequencing reactions. Samples 
were electrophoresed on a  10%  acrylamide/7.0 M  urea gel.  The 
arrowheads denote the precursor-specific protected bands, nt, nu- 
cleotide. 
slot-blotted onto nitrocellulose  (Schleicher and Schuetl, Inc., Keene, NH). 
Filters  were baked at 80°C for 2 h. Prehybridization was for 4 h at 45°C 
in 0.9 M NaCl, 0.18 M Tris-HCl, pH 8.0, 12 mM EDTA,  1% nonfat dry 
milk,  1%  SDS,  and 250 pg/ml tRNA.  Hybridizations were  in the same 
buffer containing 2  x  l06 cpm/ml for 12-24 h at 45°C.  Blots were washed 
at room temperature in 6x SSC for 1-2 h followed by two washes for 20 
rain each at 37°C in 3.0 M tetramethylammonium chloride, 50 mM Tris- 
HC1, pH 8.0, 2.0 mM EDTA, and 0.1% SDS. The final wash solution and 
temperature were  determined by following the procedure of Wood et al. 
(50). Oligonu¢leotides were end labeled using polynucleotide kinase (Boeh- 
ringer Mannheim Diagnostics,  Inc.) and [7-32p]ATP as described (30). 
Results 
The Y Flanking Sequence of the Human U1 RNA 
True Gene, pD2, Is Expressed in HeLa Cells 
Precursors to U1 RNA that are 3-15 nucle0tides longer than 
mature U1  (11, 29,  52) have been described.  To determine 
definitively whether these precursors are derived via tran- 
scription  of  3'  flanking  sequences,  we  performed  RNase 
digestion experiments.  Using the SP6 transcription system, 
we prepared 32p-labeled  RNA transcripts complementary to 
one of the true U1 RNA genes (pD2, reference 31).  As seen 
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a pD2-homologous U1 gene. U1 RNA was isolated from nuclear 
(lane 1) and cytoplasmic (lane 2) fractions of pulse-labeled HeLa 
cells using anti(U1)RNP antisera. These RNAs were hybridized  to an 
unlabeled SP6 transcript  that was terminated at the  Hpa II site 
in  pSP64cUI.  After  digestion  of unhybridized  sequences  with 
RNases A and T1, protected RNAs were purified and electropho- 
resed as in Fig. 1 except that the gel was fluorograpbed and dried 
before exposing to film. Lanes I and 2, undigested RNAs isolated 
from nuclear (lane 1 ) and cytoplasmic (lane 2) fractions. Lanes 3 
and 4, protected RNAs from cytoplasmic (lane 3) and nuclear (lane 
4) fractions. All samples were run on the same gel. The two pairs 
of lanes have been aligned in the figure to permit comparison of  the 
patterns of labeled RNAs. The asterisks denote the position of ma- 
ture U1 (lanes 1 and 2) or protected species derived from mature 
U1 (lanes 3 and 4). 
in Fig.  1, RNA transcripts were prepared that terminated at 
either the Taq I site (+115) or the Hpa II site (+73).  These 
transcripts contain 28 bases of 3' flanking sequences as well 
as 49 bases (Taq I probe) or 91 bases (Hpa II probe) of  mature 
U1  RNA complementary sequences. 
U1 RNAs were isolated from nuclear or cytoplasmic frac- 
tions of  HeLa cells and hybridized to the SP6 transcripts, fol- 
lowed by RNase digestion with RNases A and TI. As seen 
in Fig.  2,  both cytoplasmic and nuclear U1  RNA samples 
yield protected RNA fragments that represent hybridization 
to mature U1 RNA sequences (48-49 nucleotides with the 
Taq I probe and 90-91 nucleotides with the Hpa II probe). 
Protected species 6-7 nucleotides longer than expected for 
mature U1  sequences are found when cytoplasmic, but not 
nuclear, RNAs are hybridized with either of  the pD2-derived 
probes. Therefore, these HeLa cytoplasmic fractions contain 
U1 RNA species that are extended at their 3' terminus by up 
to seven nucleotides. Furthermore, these species must have 
been derived by transcription of a pD2-homologous 3' flank- 
ing sequence. 
Not all U1 RNA Precursors Are Transcribed 
from a pD2-homologous U1 Gene 
The finding that 3' flanking sequences from prototypic U1 
genes are expressed in HeLa cells agrees with the results of 
a previous S1 mapping experiment (13), but the size distribu- 
tion of the protected species is somewhat different than the 
pattern of U1 obtained by pulse-labeling (Fig. 3, lanes 1 and 
2). However, the RNAse mapping experiment shown in Fig. 
2  reveals  only the  most  stable  U1  species present in  the 
cytoplasmic fraction. Because of the difference in methodol- 
ogy, it is difficult to determine exactly which of  the precursor 
RNAs are synthesized from pD2-homologous genes. To ad- 
dress this problem, an unlabeled SP6 probe was synthesized 
from Hpa n-digested  pSP65cU1.  This  was  hybridized to 
pulse-labeled,  antibody-purified U1  RNAs,  and  the unhy- 
bridized sequences were digested with RNases A  plus T1 
as before. By restricting the analysis  to the pulse-labeled 
RNAs, it is possible to directly compare the pattern of pro- 
tected RNAs with the pattern of U1 precursors identified by 
pulse-chase analysis, antibody selection, and hybridization 
analysis. 
Lanes 1  and 2  of Fig.  3  illustrate the pattern of pulse- 
labeled RNAs recovered from HeLa cells with anti(U1)RNP 
antibody. The pattern of protected RNAs is shown in lanes 
3 and 4 of Fig. 3. If all of the U1 precursors present in lanes 
1 and 2 are derived by transcription of 3' flanking sequences 
of pD2-homologous genes, then the pattern of protected spe- 
cies should be identical to the total pattern of U1 precursors 
used  for  the  RNase  protection  experiment.  The  results 
shown in Fig. 3 demonstrate that the pD2 gene protects the 
mature U1 portion of the precursors, but only a subset of 3' 
tails from digestion by RNase A plus T1. Thus, there is a 
large accumulation of radioactive species in lane 3 that mi- 
grate at the position of protected mature U1 sequences. The 
fact that there is a specific increase in the material that mi- 
grates at the position of protected mature U1 sequences sug- 
gests that the shift in pattern is not due to artifactual nibbling 
of  the nuclease at perfectly  matched hybrids. This conclusion 
is supported by the work of other groups, who have found 
that digestion with RNase A and T1 can be used to detect sin- 
gle-base mismatches  in both RNA-DNA  and  RNA-RNA 
duplexes with a  minimum of nonspecific activity (34,  37, 
49). However, since neither nuclease will cleave after mis- 
matched A residues, it is difficult to draw further conclusions 
from the pattern of protected species produced by this type 
of analysis. In the case of the experiment shown in Fig.  3, 
this difficulty is compounded by the fact that the RNA sam- 
pies used in this experiment were labeled with [3H]uridine 
for only 25 min in vivo. Hence, the patterns of labeled RNA 
shown in this figure do not reflect the steady-state popula- 
tions of U1 precursors from HeLa cells. Nevertheless, it is 
clear that the SP6 true gene probe does not protect the entire 
ladder of pulse-labeled U1 precursors from nuclease diges- 
tion. This result suggests that some 3' tails on U1 precursors 
are not derived by transcription of the 3' flanking sequence 
found in pD2.  Further experiments using specific oligonu- 
cleotide probes confirm this conclusion. 
Variant 3' Flanking Sequences Are Transcribed 
in HeLa Cells 
If  only some of the U1 precursors have 3' tails corresponding 
to the 3' flanking sequences found in pD2, what are the se- 
quences of the remaining species? Examination of the pub- 
lished sequences of five class I U1 pseudogenes reveals that 
despite extensive homology within both coding and flanking 
regions,  the  immediate 3'  flanking  sequences  differ from 
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5'-TTTCCCCTGACTTTCTG-3'  pD2 
5'-TTTCCCCTGA~TTT~TG-3'  pU 1-6 
5'-TTTCCCCTGATTTTTTG-3'  pUl.1 
5'°TTTCCCCTGA~TTT~TG-3 '  pU1.15 
Oligomer 
3'-AAAGGGGACTGAAAGAC-5' 
3'-AAAGGGGACTTAAAAAC-5' 
3'-AAAGGGGACTAAAAAAC-5' 
plusm¢r  .  Figure  4.  Oligonucleotides 
complementary to variant U1 
IO  ,,  3' flanking sequences. The un- 
derlined nucleotides designate 
the  positions  of  divergence 
*  *  *  from  the  prototypic  U1  se- 
CO  quence. *Reference 31; **ref- 
*  *  *  erence 35; ***reference  9. 
those found in pD2-homologous true genes in every case (9, 
35). Two particular 3' flanking sequence variants are found 
in multiple pseudogenes (Fig. 4). Instead of the prototypic 
flanking  sequence  -ACTTTCI~,  two  pseudogenes  (UI.1 
and Ul.15) have the sequence -ATTTITI~, and two more 
(U1.4  and  pU1-6)  have  a  sequence  of the  form  -AAT- 
TTT(T)G.  The  occurrence of these  variant  sequences  in 
more than one pseudogene sequence raises the possibility 
that functional U1  genes exist that have these flanking se- 
quences.  To directly test this  hypothesis,  we  synthesized 
oligodeoxynucleotide probes complementary to these vari- 
ant sequences as detailed in Fig. 4. 
Since our data suggest that the most prevalent precursors 
contain only four to eight extra nucleotides at the 3' end of 
the mature U1 sequence, the probes were designed to overlap 
the mature sequence for nine nucleotides. This overlap is not 
in itself sufficient to allow hybridization to mature U1  se- 
quences under the conditions used, but it does provide a long 
enough contiguous stretch of sequence to prime hybridiza- 
tion within the immediate 3' flanking sequences. The oligo- 
nucleotides contain mismatches with the pD2 gene at the 
underlined positions. These mismatches are sufficient to pre- 
vent hybridization of the oligonucleotides to an SP6 tran- 
script of the pD2 gene sequence (see Materials and Methods 
for hybridization conditions). The specificity of hybridiza- 
tion is shown in Fig. 5. Total RNA from nuclear and cyto- 
plasmic fractions of HeLa and K562 erythroleukemia cells 
was  slot-blotted alongside an SP6 transcript derived from 
pD2 (see Fig.  1) and hybridized to the end-labeled oligonu- 
cleotides. As shown, the only oligonucleotide that hybridizes 
to  the  SP6  transcript  is  3'-AAA~ACIV~AAGAC-5' 
(Plusmer),  which  is  completely complementary to  pD2. 
None  of the  probes  hybridize  to  tRNA,  confirming  the 
specificity  of the  hybridization  and  washing  conditions. 
Thus,  hybridization under these conditions requires more 
than the  I0 contiguous bases that are common to all three 
oligonucleotides.  However,  both  3'-AAAGCK~GACTTA- 
AAAAC-5'  (IO)  and  3'-AAA~ACI"AAAAAAC-5' 
(CO)  (see Fig.  4) hybridize to both HeLa and K562 total 
RNA. This result suggests that sequences complementary to 
these oligonucleotides are expressed in both of these two cell 
lines. 
In the samples shown, there is significantly more hybridiz- 
ing material in the HeLa nuclear samples than in the corre- 
sponding  samples  from K562  cells.  We have noted some 
variability in the relative intensity of hybridizing species in 
Figure  5.  Hybridization  of end-la- 
beled oligonucleotides to HeLa total 
RNA  and  K562 total  RNA.  Total 
RNA was isolated from nuclear and 
cytoplasmic fractions of HeLa cells 
and K562 erythroleukemia cells by 
phenol extraction.  10 gg of nuclear 
RNA and 40 ~tg of cytoplasmic RNA 
were  loaded  onto  slot  blots  along 
with  an  aliquot  of a  U1  RNA-ho- 
mologous SP6 transcript  from Rsa 
I-digested pSP64U1. 10 ~tg of tRNA 
was  also  blotted  as  a  background 
control.  Oligonucleotides were end 
labeled and hybridized to total RNA 
as described in Materials and Meth- 
ods. All of the samples are from the 
same  hybridizations  and  represent 
identical exposures (2 d). 
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sequences other than the true U1 RNA se- 
quence. Total RNA was isolated from pulse- 
labeled  and  overnight-labeled (B)  HeLa 
cells.  These  RNAs  were  hybridized  to 
nitrocellulose-immobilized  M13 DNA con- 
mining  sequences  complementary  to  131 
RNA.  Hybrid-selected  sequences  were 
eluted  from  the  filters, phenol  extracted, 
and ethanol precipitated. Equal aliquots of 
the reconstituted RNAs were then slot blot- 
ted (A) or run on a 10% acrylamide gel and 
fluorographed (B and C). (A) 10 I.tg  of unla- 
beled total nuclear RNA, 40  ~tg of unla- 
beled  total  cytoplasmic RNA,  10  I~g  of 
tRNA,  equal  aliquots of SP6  transcripts, 
and  an  equal  amount  of hybrid-selected 
RNA loaded onto the gels in B and C were 
slot blotted onto nitrocellulose. Hybridiza- 
tion with end-labeled oligonucleotides and 
conditions were as described in Materials 
and Methods.  The bottom row of hybrid- 
selected samples contains the pulse-labeled 
material shown in C.  These samples were 
hybridized  separately  from  the  samples 
shown in the top two rows of each group. 
Electrophoretic analysis of the nonselected 
RNAs (not shown) indicated that the selec- 
tions  did  not  quantitatively  remove  U1 
RNAs from the total RNA samples. Thus, 
quantitative comparisons between the three 
groups of samples (total RNA, long-labeled 
selections, and short-labeled selections) are 
not meaningful.  (B) Fluorograph of RNA 
isolated  from  HeLa  cells  labeled  with 
[3H]uridine for 16 h. Lane 1, 6 ltg of total 
nuclear RNA; lane 2, hybrid-selected nu- 
clear RNA; lane 3,  10 ltg of total cytoplas- 
mic RNA; lane 4, hybrid-selected  cytoplas- 
mic RNA. The exposure time in each case 
was 30 d. (C) Fluorograph of RNA isolated 
from HeLa cells labeled with [3H]uridine 
for 45 rain. Lane 1, 10 Itg of total cytoplas- 
mic RNA; lane 2, hybrid-selected  cytoplas- 
mic RNA; lane 3,  10  gg of total nuclear 
RNA;  lane  4,  hybrid-selected  nuclear 
RNA. Lanes 1 and 3 are from an 18-h ex- 
posure of the autoradiogram. Lanes 2 and 
4 are from a 30-d exposure of the same au- 
toradiogram. 
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to Fig. 6 A), which we suspect is due to differences in the 
efficiency of cell fractionation. Accordingly, we wish to em- 
phasize the operational nature of our designations of cellular 
localization.  Given this limitation, we do not ascribe any 
significance to the differences noted between the two cell 
lines. However, the relative intensities of the signals obtained 
with the different oligonucleotides was quite reproducible. 
Although there was some variation in the specific activity of 
the three probes from experiment to experiment, hybridiza- 
tion with Plusmer and CO routinely yielded stronger signals 
than hybridization with IO. This not only provides some in- 
formation regarding  the  relative  abundance  of these  se- 
quences  in  RNA  from  the  two  cell  types,  but  provides 
confirmation that IO and CO are recognizing different se- 
quences. 
I0 and CO Specifically Recognize U1 RNA Sequences 
To determine if the hybridization of the variant oligonucleo- 
tides to total RNA was actually due to hybridization to U1 
RNA sequences, U1 RNA was purified by hybridization se- 
lection before hybridization. Fig, 6 A shows that the hybrid- 
selected, pure U1 RNAs, hybridize to all three of the end- 
labeled oligonucleotides under conditions that do not permit 
hybridization of the  variant  oligonucleotides to  the  pD2 
flanking sequences. Again, only Plusmer hybridizes to the 
SP6 transcript as well as to the selected RNA. Rehybridiza- 
tion of these filters to a  coding region probe confirms the 
presence of equal quantifies of the SP6 true U1 transcript on 
all three sets of filters (data not shown). 
Since  samples prepared by hybridization selection may 
contain contaminating RNA, we analyzed the purity of our 
hybrid-selected samples by electrophoresis. The RNA used 
for the hybrid selections shown in Fig. 6 A was isolated from 
HeLa cells that were prelabeled with [3H]uridine.  Aliquots 
of the [3H]uridine-labeled,  hybrid-selected samples equiva- 
lent to that used for the slot blots shown in Fig. 6 A were elec- 
trophoresed on 10 % acrylamide gels and visualized by fluo- 
rography.  As  shown in  Fig.  6,  B  and  C,  these  selection 
experiments resulted in the isolation of pure U1 RNA from 
both nuclear and cytoplasmic samples. The long-labeled U1 
produced a single band in the nuclear lane after fluorogra- 
phy, while the cytoplasmic precursor species were not visible 
(Fig. 6 B). (The low recovery of material from the cytoplas- 
mic sample in this experiment is consistent with the low level 
of hybridization observed in this sample in Fig. 6 A, top row 
of hybrid-selected samples.) To rule out the possibility that 
the hybrid-selected U1 samples were contaminated with un- 
stable RNAs that would not be seen in long-labeled RNA 
samples,  the hybrid selections were  repeated with pulse- 
labeled RNAs (bottom row of hybrid-selected samples in 
Fig.  6,  A and C).  Although some diffuse radioactivity is 
present at the top of the hybrid-selected lanes in Fig. 6  C, 
the major species in these samples are clearly the normal 
pattern of U1 precursors. Taken as a whole, these results sug- 
gest that the variant oligonucleotides are specifically recog- 
nizing U1 RNA sequences. 
The recovery of diffuse, higher molecular weight species 
in the pulse-labeled hybrid selection experiments raises the 
possibility that the variant oligonucleotides are hybridizing 
to unstable aberrant transcripts that may not be physiologi- 
cally active. To evaluate this possibility, and to provide fur- 
Figure 7. IO and CO recognize RNP antiscra-selected  RNA. RNA 
was isolated from unlabeled HeLa cells using Ul-specific antisera 
(RNP). Equal aliquots of  antibody-selected  RNAs were slot blotted 
onto nitrocellulose along with 10 pg of tRNA and an equal amount 
of an SP6 transcript of I31 RNA. Hybridization was as in Fig. 6. 
The SP6 blot can be seen in the bottom row of each group in Fig. 
6 A. Exposure time was identical to that shown in Fig. 6 A. 
ther confirmation of the specificity of the hybridization con- 
ditions, we also analyzed the hybridization of the variant 
oligonucleotides to  U1  RNAs  isolated with  anti(U1)RNP 
antisera. This strategy confines the analysis to U1 molecules 
that have been assembled into ribonucleoprotein complexes. 
In  agreement  with  the  results  outlined  above,  antibody- 
purified U1  RNA from both nuclear and cytoplasmic cell 
fractions does hybridize to the variant sequences under con- 
ditions that do not permit hybridization of the variants to the 
pD2 flanking sequences (Fig. 7). (The SP6 controls for these 
samples are shown in Fig. 6 A). This result is consistent with 
the hypothesis that the variant U1  sequences are packaged 
into functional RNP complexes. 
Discussion 
Our investigation of the sequence structure of U1 precursors 
has  revealed that multiple precursor  species  up  to  seven 
nucleotides  longer than  mature  U1  are  transcribed  from 
genes with 3' flanking sequences identical to those found in 
the characterized true  U1  genes.  This  finding is  in good 
agreement with previous studies that have found that tran- 
scription of prototypic U1 genes begins at the cap site (43) 
and extends past the end of  the mature U1 sequence (20). The 
current work also provides an important link between these 
studies of U1 transcription and the previous description of 
multiple, unstable U1 species found in cytoplasmic fractions 
from HeLa cells (29).  The RNase mapping studies demon- 
strate that the multiple species represent true length hetero- 
geneity of the pre-U1  species, and that these U1 precursors 
are indeed longer than the +3 nucleotide species described 
by others (11, 52). 
An unexpected result of the RNase mapping experiments 
was that not all of the precursor species identified by pulse 
labeling and antibody precipitation were  direct transcrip- 
tional extensions from prototypic U1 true genes. This finding 
was confirmed by hybridization of U1 RNA samples to two 
oligonucleotides complementary to  specific variants of 3' 
flanking sequences found in previously characterized pseu- 
dogenes. These experiments indicate that U1 genes with vari- 
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that transcripts containing these variant flanking sequences 
become packaged with proteins to form ribonucleoprotein 
complexes. We wish to emphasize that there may be signifi- 
cantly more heterogeneity in the 3' tails of U1 precursors 
than we have identified with the two oligonucleotide probes 
used in this study. 
One of the important questions that our studies have not 
addressed is whether genes previously characterized as class 
I pseudogenes can be transcribed in vivo to produce func- 
tional transcripts. Although the sequences used to construct 
probes were taken from published pseudogene sequences, it 
is possible that there are functional U1 genes that have vari- 
ant 3' flanking sequences while coding for a mature RNA 
that is identical to the published sequence of U1 from HeLa 
cells (5).  The alternative possibility, that some presumed 
class I pseudogenes are really transcribed in some cells, is 
equally interesting. 
Variant U1 RNAs have been described in chickens (42), 
Xenopus (8,  12,  19), and mice (15, 27).  However,  since hu- 
man U1 RNA from HeLa cells yielded an unambiguous se- 
quence, genes that differ from the RNA sequence by as little 
as  one  nucleotide have been designated as  pseudogenes. 
Nevertheless,  neither  the  RNA  sequencing  data  nor  our 
RNase mapping studies exclude the possibility that there is 
scattered low level sequence heterogeneity in mature human 
U1 RNA. The regulated expression of U1 RNAS with variant 
sequences would have obvious implications for the regula- 
tion of alternative splicing events (27). Our experiments sug- 
gest that variant U1 flanking sequences are expressed in at 
least two different human tumor cell lines. We are investigat- 
ing the possibility that these variants might be differentially 
regulated in different cell types. 
In theory, it is not necessary to invoke heterogeneity within 
the coding sequence to produce a heterogeneous population 
of U1 RNPs. The formation of U1 ribonucleoprotein com- 
plexes in vivo involves the interaction of snRNP proteins 
with U1 precursors rather than mature U1 (29).  Although it 
is not known whether complete assembly of U1  RNP re- 
quires the precursor-specific 3' tail, assembly experiments 
using mature U1 RNA have resulted in the formation of in- 
complete  RNA-protein  complexes  (46).  While  there  are 
many possible explanations for this result, one interesting 
possibility is that the 3' tail is transiently used in vivo as a 
protein binding  site.  According to this  scenario,  proteins 
bind to the 3' tail and order subsequent protein assembly 
within the mature region before the tail is lost upon process- 
ing.  This  hypothesis  would  predict  that  molecules  with 
different 3' tails might become associated with different pat- 
terns of proteins. The observation that only a subset of pre- 
U1 snRNPs are recognized by patient anti-La antibodies (28) 
is entirely consistent with this hypothesis, as is the heteroge- 
neity noted when intact snRNP particles are isolated (14, 16). 
The diversity in U1  precursors described here provides a 
possible basis for the decision as to which precursors acquire 
a given set of proteins. 
It is particularly interesting in this regard that both the var- 
iant 3' flanking sequences from which we constructed our 
oligonucleotide probes contain the putative recognition site 
for the binding of the Sm antigen. The sequence A(U)nG 
with n ranging from 3-6 is required for the binding of the 
Sm antigenic proteins to U2 RNA in Xenopus (33),  and a 
Table L Evolutionary Conservation of  Sm Binding 
Sites at the 3' Ends of U1 Genes 
Species  Locus  3' Sequence  Reference 
Human  HUI-1  -  ACTTTCTG  (31) 
Human  U1.4  -  AATTTTG  (9) 
Human  U1.1  -  ATTTTTTG  (9) 
Human  U1.15  -  ATTTTTTG  (9) 
Human  pU1-6  -  AATTTTTG  (35) 
Xenopus  xU1A  -  ATTTG  (19) 
Chicken  U1  2.5  -  ATTTG  (10) 
Chicken  U1  52a  -  ATTTG  (10) 
Rat  3 - 1A  -  ATTTG  (44) 
Rat  3 - 1B  -  ATTTG  (44) 
Mouse  U1B  -  ATTTTTG  (32) 
Sm antigen binding site, A(U)~G, n  =  3-6 (33). 
similar sequence  has  been  implicated as  a  protein bind- 
ing site in human U1  (6,  23).  Interestingly, the sequence 
A(U)nG  is also found at the immediate 3' terminus of the 
U1 coding sequence in Xenopus (8, 19), chickens (10), mice 
(32),  and rats (44)  (Table  I).  The conservation of this se- 
quence through evolution gives further support to the hy- 
pothesis that the 3' tails of U1 precursors might have impor- 
tant functional roles. 
The production of U1 transcripts from variant genes has 
several other important implications.  Flanking sequences 
from human U1 true genes have been thought to be highly 
conserved. In fact, probes derived from the 5' flanking se- 
quences of a prototype human U1  gene have been used to 
define the number and chromosomal location of active hu- 
man U1 genes (3, 24-26,  38).  If, as our data suggest, there 
are active genes with variant flanking sequences, it would be 
worthwhile to extend this analysis to include the flanking se- 
quences from other active genes. Previous in vitro mutagen- 
esis studies directed at characterizing the sequences respon- 
sible for the initiation and termination of U1 transcriptions 
have also been focused around the study of the flanking se- 
quences from the prototype gene. Our data suggest that the 
conclusions drawn from these studies may not be applicable 
to all expressed U1 genes. Particularly interesting in this re- 
spect is the fact that at least one of the pseudogenes (pU1-6, 
reference 35), which has a 3' flanking sequence complemen- 
tary to one of our oligonucleotide probes, has a true TATA 
box located at position -34 from the cap site. This raises the 
possibility that some functional U1 genes do contain the stan- 
dard RNA polymerase II transcription signals. 
As noted above,  the expression of multiple U1  species 
seems to be a general phenomenon in vertebrates. Although 
no direct links have been established, it is tempting to specu- 
late that this variability is significant in the regulation of 
tissue-specific or developmentally regulated splicing (7, 21, 
27). There is little corresponding data concerning the possi- 
bility of heterogeneity in snRNP proteins, which have been 
characterized only as bands in one-dimensional acrylamide 
gels. In concert with our continuing studies of heterogeneity 
of snRNA expression, we have also begun to examine the 
structure and organization of genes for snRNP proteins (48). 
Ultimately we hope to combine the information obtained 
from these two lines of investigation to determine how U1 
snRNP heterogeneity might relate to the function of this 
RNA-protein complex in splicing. 
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